Filed before 2025Filed 17 November 2021
Variant Bio, Inc. has sold $105M so far
Variant Bio, Inc., a biotech company based in Seattle, WA, has sold $105M so far in its equity round, according to a filing dated 17 November 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 17 November 2021
- First filed
- 4 November 2021
- Round
- Equity round (amended filing)
- Amount sold
- $105M
- Offering size
- $105M
- Investors so far
- 12
- Based in
- Seattle, WA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 91% of the 2,220 tracked raises with an amount filed in 2021, and than 85% of the 177 in biotech.
Variant Bio, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 17 Nov 2021 | Amended filing | $105M | This raise |
| 4 Nov 2021 | New filing | $95M | This raise |
| 5 Aug 2020 | New filing | $6.1M | Another raise |
| 10 Oct 2019 | New filing | $16.6M | Another raise |
More with Lux Ventures on the board
- Reflect Orbital Inc.$28.7M
- Rivington Holdings Inc.$17.7M
- Eikon Therapeutics, Inc.$141M
- KYMETA Corp$80.6M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.